COVID-19 pandemic brought with it a complete disruption to the existing normal operating procedures in most of the industries. Behaviors, patterns and priorities are fundamentally shifting, globally. The uncertainties are overwhelming but new opportunities are shaping up too.
To emerge stronger from this pandemic, organizations have to not just outmanoeuvre these uncertainties but also realize opportunities in this new Digitally-driven world.
Learn what to do Now, Next and Beyond..
- All
- Banking
- Business Continuity
- Clincal Trials
- Cost Control
- Digital Opportunities
- Financial Services
- Risk Management
- Supply Chain
- Lifesciences
- Wealth Management
Digital Transformation/ Insulation for Wealth Management Post COVID 19
With the customer service teams running on reduced capacity and nervous customers anxious about their investments, an up-to-date business continuity planning is essential to protect your business from personnel-related disruptions.
Learn More
COVID-19 – Driving Wealth Managers to optimize their Advisor Engagement using Data Analytics
COVID-19 pandemic has brought a significant change in the way financial advisors manage their practices, clients and home office communication. Along with the data driven client servicing platforms, smooth transition...
Learn More
COVID-19 Control Room
A COVID-19 Control Room to assess and combat impact of Covid-19 Risk on critical Pharma Decisions leveraging External Signals to generate powerful Insights.
Learn More
HCP Engagement in COVID world – Now & Next: A guide for Bio-Pharmaceutical Companies
COVID-19 pandemic brought with it a complete disruption to the existing normal operating procedures in most of the industries. The unprecedented situation due to the pandemic has struck some of the business functions disproportionately hard.
Learn More
AI enabled credit risk management for the post COVID world
The COVID-19 pandemic has led to a breakdown of Risk models across banks. The global economic crisis of this magnitude has led to a sudden shift in the credit profile of the customers.
Learn More
Rapid Credit Risk Decisioning post COVID-19 : An approach note for banks and lending institutions
While the reckless overextension of credit lines by lenders and banks was the root cause of the financial crisis of 2007-09 and it had the US primarily as its central point, this time the financial crisis has been caused by a virus with rapidly evolving geographical centers and covering almost the entire world.
Learn More
Navigating the impact of COVID-19: A COVID Control Room for Pharma Supply Chains
Webinar on AI powered COVID Control Room for Pharma Supply Chain teams - for forecasts, time to response for critical events, mitigating the overall impact of COVID-19.
Learn More
Rethinking Credit Risk Management post COVID-19
The magnitude of the spread of the COVID-19 pandemic has forced the world to come to a virtual halt, with a sharp negative impact on the economies worldwide.
Learn More
Accelerated, AI-enabled Real-World Insights for scale and faster action, in post-Covid world
Drawing upon our experience from fintech and e-commerce companies, we help organizations better manage and minimize risk through our Risk analytics offering.
Learn More
COVID crisis will force new priorities for Wealth Management Industry
Covid-19 has led to a socio-economic disruption and majorly affected wealth management space amid volatile markets. In order to stay resilient, what do wealth management firms need to follow?
Learn More
Navigating the impact of Covid-19: A Covid Control Room for Pharma Supply Chains
Strategies leveraging the available data and tools can help pharma companies win the battle against this pandemic. For insights on the challenges that lie ahead and the approach to tackle them, so you are better prepared, read this blog.
Learn More
RWE is growing as a top strategic priority for FDA: Are Pharma and CROs ready?
“As the breadth and reliability of RWE increases, so do the opportunities for FDA to make use of this information”, noted Scott Gottlieb, former FDA Commissioner National Academies of Science, Engineering, and Medicine while examining the impact of RWE on medical product development.
Learn More
Secret Ingredients for Real World Insights at Scale – Innovative Patient Data and Machine Learning
Making rapid decisions across various healthcare decision points has never been more critical. Read this blog to see, How a Real World Analytics Platform driven approach can deliver impact and value across RWD Studies as well as patient insights using Data Science at scale.
Learn More
Managing Pharma Supply Chains In Times of Covid-19
Fragile and complex Pharma supply chains are under immense pressure right now. To understand how Analytics and Data Science can be leveraged to overcome the key challenges being faced, read this blog.
Learn MoreGet In Touch
We are always looking for new ideas and new partnerships. Contact us to see how we can help you.
